Recently observing the dynamics of Injective, you will find that it is doing something unprecedented in the crypto world: truly integrating traditional financial assets and on-chain liquidity. The native EVM is about to launch, with over 40 dApps and infrastructure providers ready to join, which not only signifies ecological expansion but also greatly lowers the development threshold for financial-grade applications, making the vision of MultiVM a reality.
The capital market's attitude towards Injective is highly indicative. Pineapple Financial, a company listed on the New York Stock Exchange, raised $100 million to purchase INJ on the open market, reflecting a long-term value judgment rather than short-term speculation. Meanwhile, the Injective ETF is set to launch in the United States, allowing both institutions and ordinary investors to access INJ through legitimate channels on Wall Street, further enhancing liquidity and market recognition.
Injective's RWA (Real World Assets) on-chain plan is particularly eye-catching. Stocks, gold, foreign exchange, and digital asset government bonds have all been realized on-chain, even including popular stocks like Nvidia. This means that DeFi is no longer limited to virtual assets; it is beginning to directly connect with the real-world financial market, providing investors with transparent, low-cost, and composable financial tools.
In a market environment flooded with public chains and rampant noise, Injective is steadily occupying a position in financial infrastructure through both technology and capital. This accumulation and realization of value carries more weight than any short-term speculation.
The above content is only a personal analysis and does not constitute any investment advice.
